Bevacizumab in Combination with TAS‐102 Improves Clinical Outcomes in Patients with Refractory Metastatic Colorectal Cancer: A Retrospective Study

por Fujii, Hironori, Matsuhashi, Nobuhisa, Kitahora, Mika, Takahashi, Takao, Hirose, Chiemi, Iihara, Hirotoshi, Yamada, Yunami, Watanabe, Daichi, Ishihara, Takuma, Suzuki, Akio, Yoshida, Kazuhiro
Publicado 2019

Real-world data of the association between quality of life using the EuroQol 5 Dimension 5 Level utility value and adverse events for outpatient cancer chemotherapy

por Hirose, Chiemi, Fujii, Hironori, Iihara, Hirotoshi, Ishihara, Masashi, Nawa-Nishigaki, Minako, Kato-Hayashi, Hiroko, Ohata, Koichi, Sekiya, Kumiko, Kitahora, Mika, Matsuhashi, Nobuhisa, Takahashi, Takao, Okuda, Kumiko, Naruse, Masayo, Ishihara, Takuma, Sugiyama, Tadashi, Yoshida, Kazuhiro, Suzuki, Akio
Publicado 2020

Pharmaceutical intervention for adverse events improves quality of life in patients with cancer undergoing outpatient chemotherapy

por Fujii, Hironori, Ueda, Yukino, Hirose, Chiemi, Ohata, Koichi, Sekiya, Kumiko, Kitahora, Mika, Sadaka, Shiori, Yamamoto, Senri, Watanabe, Daichi, Kato-Hayashi, Hiroko, Iihara, Hirotoshi, Kobayashi, Ryo, Kaburaki, Miho, Matsuhashi, Nobuhisa, Takahashi, Takao, Makiyama, Akitaka, Yoshida, Kazuhiro, Hayashi, Hideki, Suzuki, Akio
Publicado 2022

Doublet or Triplet Antiemetic Prophylaxis for Nausea and Vomiting Induced by Trastuzumab Deruxtecan: an Open-Label, Randomized, and Multicenter Exploratory Phase 2 Study

por Iihara, Hirotoshi, Shimokawa, Mototsugu, Bando, Hiroko, Niwa, Yoshimi, Mizuno, Yutaka, Kawaguchi, Yoshihiro, Kitahora, Mika, Murakami, Akari, Kawai, Masaaki, Ishida, Kazushige, Takeuchi, Makoto, Ishihara, Kazuhiro, Iyoda, Tomokazu, Nakada, Takumi, Ogiso, Atsuko, Kojima, Yasuyuki, Kumagai, Fumiyoshi, Sawa, Aya, Mori, Ryutaro, Higuchi, Kosuke, Furuta, Tomoko, Kamei, Yoshiaki, Tsuchiya, Masami, Terasaki, Azusa, Yamamoto, Senri, Kitazawa, Mai, Okazaki, Mai, Suzuki, Akio, Futamura, Manabu
Publicado 2023